Search by Drug Name or NDC

    NDC 71929-0070-28 ReCellTis 12000; 600; 105; 150000 [USP'U]/30g; mg/30g; mg/30g; [USP'U]/30g Details

    ReCellTis 12000; 600; 105; 150000 [USP'U]/30g; mg/30g; mg/30g; [USP'U]/30g

    ReCellTis is a TOPICAL CREAM in the HUMAN OTC DRUG category. It is labeled and distributed by CellNovation Technology. The primary component is BACITRACIN ZINC; LIDOCAINE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE.

    Product Information

    NDC 71929-0070
    Product ID 71929-070_d28337a3-e5f0-a89d-e053-2995a90a5ec5
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name ReCellTis
    Proprietary Name Suffix Wound Cream
    Non-Proprietary Name bacitracin zinc, neomycin sulfate, polymyxin b sulfate, lidocaine HCl
    Product Type HUMAN OTC DRUG
    Dosage Form CREAM
    Route TOPICAL
    Active Ingredient Strength 12000; 600; 105; 150000
    Active Ingredient Units [USP'U]/30g; mg/30g; mg/30g; [USP'U]/30g
    Substance Name BACITRACIN ZINC; LIDOCAINE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
    Labeler Name CellNovation Technology
    Pharmaceutical Class Amide Local Anesthetic [EPC], Amides [CS], Aminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Antiarrhythmic [EPC], Decreased Cell Wall Synthesis & Repair [PE], Local Anesthesia [PE], Polymyxin-class Antibacterial [EPC], Polymyxins [CS]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part333B
    Listing Certified Through 2023-12-31

    Package

    NDC 71929-0070-28 (71929007028)

    NDC Package Code 71929-070-28
    Billing NDC 71929007028
    Package 28 g in 1 TUBE (71929-070-28)
    Marketing Start Date 2019-10-01
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 8902aa55-547d-787f-e053-2a95a90a2289 Details

    Revised: 12/2021